LIMERICK, Ireland, Aug. 31,
2023 /CNW/ - (TSX: KSI) (OTC: KSIOF), a leader
in digitizing and automating validation and quality processes, is
pleased to announce that it has signed a three-year Master Services
Agreement ("the Agreement") with a US-headquartered manufacturer
and distributor of medical supplies. The Agreement, which
initially is for computer systems validation ("CSV") for software
utilized in medical devices, allows the company to scale Kneat to
all its global validation processes. Implementation will
begin immediately with go-live expected in Q4 2023.
With over 30,000 employees, the company serves healthcare
facilities in over 100 countries from dozens of distribution
centers and over a dozen manufacturing sites.
"The functionality and maturity of the Kneat Gx platform, our
strong customer references, and our knowledgeable team all
contributed to the win we are announcing today," stated
Eddie Ryan, Chief Executive Officer
of Kneat. "Today's announcement is an excellent example of
how Kneat Gx is gaining further traction beyond our initial sweet
spot in pharma into device manufacturing and distribution. That the
biggest companies throughout the life sciences supply chain choose
Kneat for digital validation speaks volumes about the quality of
our software, our team, and our ability to execute."
About Kneat
Kneat, a Canadian company with operational headquarters in
Limerick, Ireland, develops and
markets the next-generation Kneat Gx SaaS platform. Multiple
business work processes can be configured on the platform from
equipment to computer validation, through to quality document
management. Kneat's software allows users to author, review,
approve, execute testing online, manage any exceptions, and
post-approve final deliverables in a controlled FDA 21 CFR Part 11/
EU Annex 11-compliant platform. Macro and micro report dashboards
enable powerful oversight into all systems, projects and processes
globally. Customer case studies are reporting productivity
improvements in excess of 100% and a higher data integrity and
compliance standard. For more information
visit www.kneat.com.
Cautionary and Forward-Looking
Statements
Except for the statements of historical fact contained herein,
certain information presented constitutes "forward-looking
information" within the meaning of applicable Canadian securities
laws. Such forward-looking information includes, but is not limited
to, the relationship between Kneat and the customer, Kneat's
business development activities, the use and implementation
timelines of Kneat's software within the customer's validation
processes, the ability and intent of the customer to scale the use
of Kneat's software within the customer's organization, our ability
to win business from new customers and expand business from
existing customers, our expected use of the net proceeds from
the IPF Facility and/or any future offering, the anticipated
effects of the IPF Facility and/or any future offering on our
business and operations and the compliance of Kneat's platform
under regulatory audit and inspection. While such forward-looking
statements are expressed by Kneat, as stated in this release, in
good faith and believed by Kneat to have a reasonable basis, they
are subject to important risks and uncertainties. As a result of
these risks and uncertainties, the events predicted in these
forward-looking statements may differ materially from actual
results or events. These forward-looking statements are not
guarantees of future performance, given that they involve risks and
uncertainties.
Kneat does not undertake any obligation to release publicly
revisions to any forward-looking statement, except as may be
required under applicable securities laws. Investors should not
assume that any lack of update to a previously issued
forward-looking statement constitutes a reaffirmation of that
statement. Continued reliance on forward-looking statements is at
an investor's own risk.
SOURCE kneat.com, inc.